These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 18778112)

  • 1. Recombinant antibodies as therapeutic agents: pathways for modeling new biodrugs.
    Aires da Silva F; Corte-Real S; Goncalves J
    BioDrugs; 2008; 22(5):301-14. PubMed ID: 18778112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
    Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
    Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Historical development of monoclonal antibody therapeutics.
    Nissim A; Chernajovsky Y
    Handb Exp Pharmacol; 2008; (181):3-18. PubMed ID: 18071939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic monoclonal antibodies: a little history, a lot of engineering, and... some clinical successes].
    Siberil S; Dutertre CA; Boix C; Teillaud JL
    Transfus Clin Biol; 2005 Jun; 12(2):114-22. PubMed ID: 15907389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rapid discovery of engineered antibodies.
    Wang M; He M
    IDrugs; 2007 Aug; 10(8):562-5. PubMed ID: 17665332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monoclonal antibodies, 30 years of success].
    Laffly E; Sodoyer R
    J Soc Biol; 2006; 200(4):325-43. PubMed ID: 17652969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering of monoclonal antibodies and antibody-based fusion proteins: successes and challenges.
    Teillaud JL
    Expert Opin Biol Ther; 2005 Sep; 5 Suppl 1():S15-27. PubMed ID: 16187937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered antibodies take center stage.
    Huston JS; George AJ
    Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody engineering.
    Maynard J; Georgiou G
    Annu Rev Biomed Eng; 2000; 2():339-76. PubMed ID: 11701516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biotechnology and applications of antibody engineering.
    Rapley R
    Mol Biotechnol; 1995 Apr; 3(2):139-54. PubMed ID: 7620975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant antibody constructs in cancer therapy.
    Hudson PJ
    Curr Opin Immunol; 1999 Oct; 11(5):548-57. PubMed ID: 10508712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal and recombinant antibodies, 30 years after ..
    Laffly E; Sodoyer R
    Hum Antibodies; 2005; 14(1-2):33-55. PubMed ID: 16424599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guest editor's introduction--antibody engineering.
    Rüker F
    Arch Biochem Biophys; 2012 Oct; 526(2):85-6. PubMed ID: 22944043
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant antibodies for cancer diagnosis and therapy.
    Hudson PJ; Souriau C
    Expert Opin Biol Ther; 2001 Sep; 1(5):845-55. PubMed ID: 11728219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant antibodies for cancer diagnosis and therapy.
    Souriau C; Hudson PJ
    Expert Opin Biol Ther; 2003 Apr; 3(2):305-18. PubMed ID: 12662144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural and designer binding sites made by phage display technology.
    Hoogenboom HR; Chames P
    Immunol Today; 2000 Aug; 21(8):371-8. PubMed ID: 10916139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of antibodies from synthetic antibody libraries.
    Harel Inbar N; Benhar I
    Arch Biochem Biophys; 2012 Oct; 526(2):87-98. PubMed ID: 22244834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-chain antibodies as diagnostic tools and therapeutic agents.
    Hagemeyer CE; von Zur Muhlen C; von Elverfeldt D; Peter K
    Thromb Haemost; 2009 Jun; 101(6):1012-9. PubMed ID: 19492141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humanized antibodies as potential drugs for therapeutic use.
    Merluzzi S; Figini M; Colombatti A; Canevari S; Pucillo C
    Adv Clin Path; 2000 Apr; 4(2):77-85. PubMed ID: 11080787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.